1,099 results on '"Colombo, Carla"'
Search Results
2. Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions
3. Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
4. Large Static Testing Equipment: Design and Testing of a Settlement Facility
5. A Comparative Experimental Campaign to Estimate the Normal Interface Stiffness of Dry-Joint Masonry Structures
6. ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
7. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
8. The impact of vitamin D status on lipid profiles and atherogenic dyslipidemia markers in children and adolescents with obesity
9. Experimental characterisation of dry-joint masonry structures: Interface stiffness and interface damping
10. Large Static Testing Equipment: Design and Testing of a Settlement Facility
11. Small Bowel Neuroendocrine Tumors: Focus on Pathologic Aspects and Controversial Surgical Issues
12. Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
13. Endocrine-related adverse conditions induced by tyrosine kinase inhibitors
14. Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS/CFSPID) and Pseudomonas aeruginosa isolation
15. VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non–G551D-CFTR gating mutations
16. IMPACT OF SYSTEMIC TREATMENTS FOR ADVANCED THYROID CANCER ON THE ADRENAL CORTEX
17. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
18. Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype
19. Experimental, numerical and analytical investigations of masonry corners: Influence of the horizontal pseudo-static load orientation
20. FAM83B is involved in thyroid cancer cell differentiation and migration
21. Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis
22. Adipokines and Thyroid Malignancies
23. Liver Disease in Cystic Fibrosis
24. Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study
25. Tracking dynamic evolution of low‐ and intermediate‐risk differentiated thyroid cancer: Identification of individuals at risk of recurrence.
26. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
27. Short‐term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham‐controlled crossover study
28. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres
29. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis
30. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
31. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
32. Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
33. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
34. Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
35. Three months of COVID-19 in a pediatric setting in the center of Milan
36. Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival
37. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose
38. Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives.
39. SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium.
40. Management of liver disease and portal hypertension in cystic fibrosis: a review.
41. Il carcinoma della tiroide nell’anziano: terapia e follow-up
42. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
43. ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
44. The Relative Contribution of Food Groups to Macronutrient Intake in Children with Cystic Fibrosis: A European Multicenter Assessment
45. Eradication of early P. aeruginosa infection in children
46. Classification of cystic fibrosis (CF) lung disease patterns based on CT texture analysis and machine learning
47. Genomic Complexity and Complex Chromosomal Rearrangements in Genetic Diagnosis: Two Illustrative Cases on Chromosome 7
48. Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature
49. TUMOR LYSIS SYNDROME DURING SELPERCATINIB TREATMENT IN A PATIENT WITH MEDULLARY THYROID CANCER
50. Liver Disease in Cystic Fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.